Abstract
Allergic rhinitis affects up to 42% of children by age 6 years, but few studies have evaluated the effects of intranasal corticosteroids in children aged 2 to 5 years. To address concerns that intranasal corticosteroids may affect the hypothalamic-pituitary axis and growth of young children, researchers conducted a manufacturer-funded, randomized, double-blind, placebo-controlled study of triamcinolone acetonide aqueous nasal spray (TAA AQ) in children aged 2 to 5 years who had allergic rhinitis. Children with symptoms of allergic rhinitis for at least 1 …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
